• Print
  • Bookmark and Share
  • RSS Feeds Feeds

Christiana Care Health Services

4755 Ogletown-Stanton Road
Room 6C26
Newark, DE 19718
Direct phone: (302) 733-6156
http://www.christianacare.org

Program Description:

  The FACT-accredited BMT Program, part of the Helen F. Graham Cancer Center multidisciplinary team, offers advanced and sophisticated techniques for patients who need autologous or allogeneic (related and unrelated) PBSC or bone marrow transplants, including reduced intensity transplants.

Contact Information:

  If you have transplant-related questions, please contact Mary Sheridan, transplant center coordinator, at (302) 733-6156 or by e-mail at msheridan@christianacare.org.

Program Type:

  Adult (ages 18 to 70)

Attending Physicians:

(Medical Doctors)
 

Adult -

Frank V. Beardell, Phillip M. Blatt, Stephen S. Grubbs, Michael J. Guarino, Scott W. Hall, S. Eric Martin, R. Bradley Slease

Transplants Performed:

  Marrow/PBSC only

Cord blood transplants performed on:

  Not performed

Mismatches allowed:

For marrow, PBSC, or cord blood transplant with an unrelated donor. Match criteria may vary based on patient's age, disease type and stage.
 
Marrow/PBSC Cord Blood
Number: Two Not performed
Location: Class I or DQB1 only Not performed
helpExplain Transplant Center HLA Match Requirements

Estimated Search & Transplant Costs

Costs vary greatly from center to center, and depend on factors such as health insurance, disease type, and disease stage of the patient, as well as center-specific billing policies.
Activation of formal search$1,089
DR testing of A/B tested donors (per donor)$474
Confirmatory typing blood sample (per sample)$438
IDM sample collection/testing (per donor)$270
High resolution - HLA typing$2,717
Marrow or PBSC procurement$29,000
Cord blood procurement (including shipping fees)N/A
Cord blood typingN/A

The costs listed above are only a small part of the total cost of a transplant. Contact your transplant center to learn more about costs of actual transplant and follow-up treatment.

helpExplain Transplant Costs at Different Centers

Financial Services:

Financial services at this center could include:

  • Health insurance information
  • Financial assistance
  • Patient-related resources

Resources for financial information

If you have questions about costs and financial services at this transplant center, you can contact the center's financial representative, Mary Sheridan at (302) 733-6156 or by e-mail at msheridan@christianacare.org.

Many organizations exist to help patients with lodging, transportation and other transplant-related expenses. Visit the National Marrow Donor Program's Patient Organizations database for more information. Financial assistance resources are also listed on this Web site.

Transplant Experience

This center has been performing allogeneic transplants since 1990 and has been an NMDP transplant center since February 1997.

Transplants Performed

(Using NMDP and non-NMDP donors from Jan. 2003 to Dec. 2007 as reported by the centers)

Marrow

PBSC

Cord
Blood

Auto-
logous

Total

(by transplant type)

Total Non-
Myeloblative transplants*

Unrelated Donor - Adult 2 10 0 --- 12 5
Unrelated Donor - Pediatric 0 0 0 --- 0 0
Related Donor - Adult 0 28 0 --- 28 16
Related Donor - Pediatric 0 0 0 --- 0 0
Autologous (PBSC and Marrow) - Adult --- --- --- 90 90 ---
Autologous (PBSC and Marrow) - Pediatric --- --- --- 0 0 ---
Total (by cell source) 2 38 0 90 130 21

This center performed a total of 39 transplants, all types, in the most recent year (from June 2008 to May 2009)

*The total Non-Myeloblative transplants column shows a subset of the total number of transplants by type.

To locate centers that perform cord blood transplants, use the search tool on this site.

The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center.

helpExplain Transplant Experience

Center-Specific Analysis (Using unrelated NMDP donors)

This analysis is based on transplants performed from Jan. 1, 2003 through Dec. 31, 2007, using unrelated NMDP donors. It only includes patients who were confirmed to be either alive or deceased within one year of transplant.
  1. This center reported survival status data for 11 patients.
  2. The overall disease condition of patients treated at this center was in the high risk category (5 on a scale of 1 to 5).
  3. The observed one-year survival of these patients was 27%.
  4. The predicted one-year survival was 50% (with a 95% confidence limit that the predicted survival was between 22% and 78%).
  5. This center's observed results are similar to the predicted range for this center. The estimated national one-year survival was 56.3% in the 9,673 patients transplanted in the United States.

For help with understanding these statistics, please see How to Understand NMDP Transplant Center Statistics.

Survival by Patient's Age, Disease Type and Stage (Using unrelated NMDP donors)


This data is only based on unrelated transplants performed from Jan. 2003 to Dec. 2007. It also includes one year post-transplant follow-up, through Dec. 2008. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.

Key:
CP = chronic phase (1st or 2nd) BP = blastic phase
AP = accelerated phase CR = complete remission (1st, 2nd, 3rd or more)
RLPS = relapse PIF = primary induction failure

Diagnoses

0-10
Yrs

11-17
Yrs

18-30
Yrs

31-40
Yrs

41-50
Yrs

51-60
Yrs

> 60
Yrs

Overall

Acute Lymphoblastic Leukemia RLPS -- -- 0/1 -- -- -- 0/1 0/2
Acute Myelogenous Leukemia 1CR -- -- -- -- 0/1 -- -- 0/1
Acute Myelogenous Leukemia PIF -- -- -- 0/1 -- -- -- 0/1
Chronic Lymphocytic Leukemia -- -- -- -- 1/1 -- -- 1/1
Chronic Myelogenous Leukemia 1CP -- -- -- 1/1 -- -- -- 1/1
Chronic Myelogenous Leukemia AP -- -- 0/1 -- -- -- -- 0/1
MDS-Refractory Anemia-Excess Blasts -- -- -- -- 1/1 -- -- 1/1
MDS-Refractory Anemia-Excess Blasts in Transformation -- -- -- -- 0/1 -- -- 0/1
Multiple Myeloma -- -- -- -- -- -- 0/1 0/1
Non-Hodgkin's Lymphoma -- -- -- -- -- -- 0/1 0/1
Total -- -- 0/2 1/2 2/4 -- 0/3 3/11

helpExplain Survival by Patient Diagnosis and Age


Additional Information
Further information about this center, including the number and type of transplants performed in each of the last three years, and the support groups offered, may be found in the BMT InfoNet Transplant Center Directory: http://www.bmtinfonet.org/transplantcenters.

BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.